好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Press Release

EMBARGOED FOR RELEASE UNTIL 4 PM ET, July 01, 2020

Does Deep Brain Stimulation for Parkinson鈥檚 Increase Risk of Dementia?

MINNEAPOLIS 鈥 There鈥檚 good news for people with Parkinson鈥檚 disease. A new study shows that deep brain stimulation may not increase the risk of developing dementia. The study is published in the July 1, 2020, online issue of , the medical journal of the 好色先生. For people with advanced Parkinson鈥檚 disease, deep brain stimulation has been shown to be more effective than medication in controlling their movement problems. But research has been mixed on whether the treatment can increase the risk of developing dementia. For deep brain stimulation, electrodes are placed in certain areas of the brain to control abnormal movements. The electrodes are connected to a device placed under the skin in the upper chest. The device controls the electrical impulses. 鈥淭hese results are very encouraging for people with Parkinson鈥檚 and their families that they can take advantage of the benefits of deep brain stimulation without worrying about it increasing the likelihood of developing dementia,鈥 said study author Elena Moro, MD, of Grenoble Alpes University in Grenoble, France, and a Fellow of the 好色先生. The study involved 175 people with Parkinson鈥檚 disease with an average age of 56 who had deep brain stimulation. They had Parkinson鈥檚 for an average of 12 years when they had the stimulator implanted. Researchers then checked the people after one year, five years and 10 years to see how many people had developed dementia. After one year, four people had developed dementia, or 2.3%. After five years, 142 people were available for testing and 12 people had dementia, or 8.5%. At 10 years, 104 people were still available for testing and 31 people had dementia, or 29.8%. The overall incidence rate was 35.6 per 1,000 person-years. 鈥淭hese rates are not higher than those reported in the general population of people with Parkinson鈥檚,鈥 said Moro. 鈥淭he few studies that are available with similar disease duration have reported higher rates of dementia. Other studies of people with Parkinson鈥檚 who are taking medication for their symptoms show an incidence rate for dementia that varies from 50 to 100 per 1,000 person-years.鈥 Moro said the younger average age in her study may help explain the lower rate of dementia. Also, people with moderate to severe memory or thinking problems are not eligible to have deep brain stimulation, so the group may have been less likely overall to develop dementia than a general group of people with Parkinson鈥檚 disease. The study also looked at factors that were associated with a higher risk of dementia. Researchers found that men, older people, people who had hallucinations, people with a low score on thinking tests before surgery, and those who had a cerebral hemorrhage during the surgery to implant the deep brain stimulator were more likely to develop dementia. 鈥淜nowing these predictors may help us to select people who would respond best to deep brain stimulation and who might have a greater risk of having a poor cognitive outcome,鈥 Moro said. A limitation of the study was that a high percentage of people did not finish the study; researchers were not able to locate them or they did not respond to requests from the researchers. This could result in underestimating the overall incidence of dementia. Learn more about Parkinson's disease at , home of the 好色先生鈥檚 free patient and caregiver magazine focused on the intersection of neurologic disease and brain health. Follow Brain & Life on , and . When posting to social media channels about this research, we encourage you to use the hashtags #Neurology and #AANscience.

Brain & Life logo

GET A DOSE OF BRAIN HEALTH

Dive into a wealth of information by visiting Brain & Life庐, where you can explore the freshest updates, tips, and neurologist expert perspectives on brain disease and preventive brain health.


The 好色先生 is the leading voice in brain health. As the world鈥檚 largest association of neurologists and neuroscience professionals with more than 40,000 members, the AAN provides access to the latest news, science and research affecting neurology for patients, caregivers, physicians and professionals alike. The AAN鈥檚 mission is to enhance member career fulfillment and promote brain health for all. A neurologist is a doctor who specializes in the diagnosis, care and treatment of brain, spinal cord and nervous system diseases such as Alzheimer's disease, stroke, concussion, epilepsy, Parkinson's disease, multiple sclerosis, headache and migraine.

Explore the latest in neurological disease and brain health, from the minds at the AAN at or find us on , , , and .

For More Information*

Email media@aan.com

*While content of the 好色先生 (AAN) press releases is developed by the AAN along with research authors and Neurology® editors, we are unable to provide medical advice to individuals. Please contact your health care provider for questions specific to your individual health history or care. For more resources, visit the AAN's patient and caregiver magazine website, .